Achilles therapeutics receives approval to transfer to nasdaq capital market

London, nov. 19, 2024 (globe newswire) -- achilles therapeutics plc (nasdaq: achl) today announced that on november 15, 2024, the listing qualifications department of the nasdaq stock market llc ("nasdaq") approved the company's request to transfer the listing of the company's american depositary shares (the "adss") from the nasdaq global market to the nasdaq capital market. the transfer is expected to take effect at the opening of business on november 19, 2024.
ACHL Ratings Summary
ACHL Quant Ranking